Shanghai Fosun Pharmaceutical Group Co LtdEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 16.47 HKD | 28,232 HKD | 14,505 HKD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - HKD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 551.940.500 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Shanghai Fosun Pharmaceutical Group Co Ltd
Mitarbeiter 40.603
Handelsplatz HK
Ticker Symbol 2196
IPO Datum -
Adresse Building A, Shanghai, China, 200233
Webseite https://www.fosunpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Xiaohui Guan | Executive Co-Chairman |
| 2 | Mr. Yuqing Chen | Executive Chairman |
| 3 | Mr. Deyong Wen | Executive Vice Chairman |
| 4 | Ms. Rongli Feng | Executive President & Chief Human Resources Officer |
| 5 | Mr. Wang Xingli M.D., Ph.D. | Co-President & CEO of the Innovative Drugs Business Unit |
| 6 | Mr. Wenjie Zhang | Co-President & Co-CEO of Innovative Medicines Division |
| 7 | Mr. Xiang Li DPHIL | SVP, Co-President & CSO of the Innovative Drugs Business Unit |
| 8 | Ms. Jia Yan | Chief Accountant, Co-CFO & Assistant to the President and Employee Director |
| 9 | Ms. Yue Zhu | VP & GM of Legal Department |
| 10 | Mr. Kexin Wang | Executive Director |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.